Medtronic won CE mark for the Affera Sphere-360 catheter and completed the first cases of the device in the Horizon 360 IDE trial.
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced two major milestones for the Affera™ Sphere-360™ catheter, a first-of-its-kind, all-in-one mapping and single-shot ...
Cyclingnews on MSN
'I couldn't get out the performances and couldn't understand it' – Sam Bennett reveals off-season surgery to correct heart problem
Irishman had suffered from heart palpitations and flutters prior to November procedure ...
The cardiac mapping devices market offers opportunities driven by rising cardiovascular diseases, an aging population, and a ...
Abbott Laboratories (NYSE:ABT) Q4 2025 Earnings Call Transcript January 22, 2026 Abbott Laboratories reports earnings inline ...
A newly released policy research analysis examines how fentanyl evolved from a tightly regulated pharmaceutical product into a central driver of the global overdose crisis, highlighting the systemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback